eXoZymes, Inc.(EXOZ)

Biotechnology · Monrovia, CA

$5.52-0.25 (-4.33%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

EV/Sales Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/Sales ratio is N/A as of 2026-10-06T12:56:34.586Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:56:34.586Z.

Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 51,233,102
Total debt · period ending 2026-06-30: 1,085,035
Cash · period ending 2026-06-30: 5,652,696
TTM revenue · period ending 2026-06-30: 0

FMP input reference: 787788ea5c712995087b0511470a3bc1500b131fb4a88c1f5ff44ca2612ce4c8

EV/EBITDA|P/S Ratio|Revenue|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EXOZ EV/Sales Ratio Metrics

EV/SALES RATIO

N/A

EXOZ Competitors' EV/Sales Ratio

EXOZ

eXoZymes, Inc.

Current

Market Cap

$51.23M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs EXOZ

Market Cap

$51.12M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INMB

INmune Bio, Inc.

vs EXOZ

Market Cap

$51.58M

EV/Sales Ratio

N/A

TTM Avg

768.07x

3Y Avg

1353.01x

5Y Avg

2660.76x

APLM

Apollomics, Inc.

vs EXOZ

Market Cap

$50.51M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs EXOZ

Market Cap

$50.25M

EV/Sales Ratio

151.62x

TTM Avg

123.33x

3Y Avg

165.71x

5Y Avg

999.06x

CLNN

Clene Inc.

vs EXOZ

Market Cap

$49.96M

EV/Sales Ratio

317.95x

TTM Avg

420.85x

3Y Avg

206.07x

5Y Avg

241.56x

ELOX

Eloxx Pharmaceuticals, Inc.

vs EXOZ

Market Cap

$52.95M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs EXOZ

Market Cap

$49.50M

EV/Sales Ratio

5.77x

TTM Avg

2.45x

3Y Avg

4.17x

5Y Avg

10.47x

IMA

ImageneBio Inc

vs EXOZ

Market Cap

$53.01M

EV/Sales Ratio

N/A

TTM Avg

46.89x

3Y Avg

17.85x

5Y Avg

13.82x

BTMD

biote Corp.

vs EXOZ

Market Cap

$49.40M

EV/Sales Ratio

0.91x

TTM Avg

0.87x

3Y Avg

1.10x

5Y Avg

0.92x

NAME	MARKET CAP	EV/SALES RATIO	TTM	3Y	5Y
eXoZymes, Inc. (EXOZ)	$51.23M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$51.12M	N/A	N/A	N/A	N/A
INmune Bio, Inc. (INMB)vs ›	$51.58M	N/A	768.07x	1353.01x	2660.76x
Apollomics, Inc. (APLM)vs ›	$50.51M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$50.25M	151.62x	123.33x	165.71x	999.06x
Clene Inc. (CLNN)vs ›	$49.96M	317.95x	420.85x	206.07x	241.56x
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$52.95M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$49.50M	5.77x	2.45x	4.17x	10.47x
ImageneBio Inc (IMA)vs ›	$53.01M	N/A	46.89x	17.85x	13.82x
biote Corp. (BTMD)vs ›	$49.40M	0.91x	0.87x	1.10x	0.92x

Understanding EV/Sales

Enterprise Value (EV) = Market Cap + Total Debt - Cash

Sales = Total Revenue (TTM)

EV/Sales is commonly used because:

It works for unprofitable companies where P/E doesn't apply
Revenue is harder to manipulate than earnings
It supports comparisons across companies at different profitability stages
It is frequently used for software and other revenue-growth-focused companies

Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.

EV/Sales Ratio Formula & Definition

EV/Sales = Enterprise Value / Revenue (TTM)

Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/EBITDA P/S Ratio Revenue All Metrics